# Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

> **NCT05487300** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Utah** · enrollment: 40 (actual)

## Conditions studied

- Parkinson Disease
- Orthostatic Hypotension

## Interventions

- **DRUG:** Autonomic testing on and off levodopa

## Key facts

- **NCT ID:** NCT05487300
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-11
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05487300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05487300, "Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05487300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*